Now included 4 Clinical Practice Guidelines
NanoString Technologies, Inc.
530 Fairview Avenue N
Seattle, WA 98109
Directions and Map (Google Maps)
Phone: 888-358-NANO (888-358-6266)
Web site: www.nanostring.com
Prosigna is indicated for use in postmenopausal women with hormone receptor-positive, node-negative (Stage I or II), or node-positive (Stage II) breast cancer to be treated with adjuvant endocrine therapy.